We investigated lectin pathway cord blood concentrations in infants ... MBL, M-, L-, H-ficolin, MASP-2 and MASP-3 were measured in cord blood using EIA/TRIFMA. Multivariate logistic regression ...

Also known as OMS906, Zaltenibart is an investigational mannan-binding lectin-associated serine protease-3 (MASP-3) inhibitor. The Phase III programme will involve 120 clinical investigative sites ...

Earlier this month, we successfully resubmitted our biologics license application ("BLA") for narsoplimab, our lead antibody targeting MASP-2 and the lectin pathway of complement, in hematopoietic ...

Based on the data to date, zaltenibart is a premier alternative pathway inhibitor ... antibody targeting mannan-binding lectin-associated serine protease-3 (MASP-3), the key and most proximal ...